GB837451A - Sustained release therapeutic composition and process of preparing same - Google Patents
Sustained release therapeutic composition and process of preparing sameInfo
- Publication number
- GB837451A GB837451A GB5576/57A GB557657A GB837451A GB 837451 A GB837451 A GB 837451A GB 5576/57 A GB5576/57 A GB 5576/57A GB 557657 A GB557657 A GB 557657A GB 837451 A GB837451 A GB 837451A
- Authority
- GB
- United Kingdom
- Prior art keywords
- medicament
- mixture
- sustained release
- binder
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Abstract
A tablet to maintain a sustained release of medicament in the presence of body fluids is made from a mixture of medicament-containing granules dispersed in a medicament-free matrix, each granule consisting essentially of a mixture of a medicament and excipients consisting of a binder, a swelling agent, a hydrophobic compound solid at body temperatures and being an aluminium or alkaline-earth metal salt of higher fatty acids or a mineral wax or animal or vegetable fat and a hydrophilic compound solid at body temperatures being higher fatty acid partial esters of glycerol and propylene glycol: the matrix consisting of a mixture of equal amounts of a hydrophobic compound (as above) and an alkaline water-soluble salt of ammonium, sodium or potassium, such as trisodium phosphate. The binder may be zein or ethyl cellulose; the swelling agent may be guar gum, gum tragacanth, carboxymethyl cellulose or its sodium or potassium salts or natural clays such as bentonite. In the specific example the medicament is phenobarbitol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US837451XA | 1956-02-20 | 1956-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB837451A true GB837451A (en) | 1960-06-15 |
Family
ID=22180412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB5576/57A Expired GB837451A (en) | 1956-02-20 | 1957-02-19 | Sustained release therapeutic composition and process of preparing same |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB837451A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3322633A (en) * | 1961-02-24 | 1967-05-30 | Konink Pharmaceutische Fabrike | Pharmaceutical preparations |
US4163777A (en) * | 1977-04-29 | 1979-08-07 | Lewis/Howe Company | Controlled antacid delivery form and method of treatment therewith |
US4344968A (en) | 1978-12-09 | 1982-08-17 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical vehicle |
US4673527A (en) * | 1985-05-20 | 1987-06-16 | Autotrol Corporation | Tablet granulation |
US5556639A (en) * | 1991-01-30 | 1996-09-17 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5698221A (en) * | 1992-07-27 | 1997-12-16 | Patel; Suryakant Dahyabhai | Water-dispersible tablets |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
WO2013163738A1 (en) * | 2012-04-30 | 2013-11-07 | Mircea-Alexandru Mateescu | Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients |
-
1957
- 1957-02-19 GB GB5576/57A patent/GB837451A/en not_active Expired
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3322633A (en) * | 1961-02-24 | 1967-05-30 | Konink Pharmaceutische Fabrike | Pharmaceutical preparations |
US4163777A (en) * | 1977-04-29 | 1979-08-07 | Lewis/Howe Company | Controlled antacid delivery form and method of treatment therewith |
US4344968A (en) | 1978-12-09 | 1982-08-17 | Nippon Kayaku Kabushiki Kaisha | Pharmaceutical vehicle |
US4673527A (en) * | 1985-05-20 | 1987-06-16 | Autotrol Corporation | Tablet granulation |
US5556639A (en) * | 1991-01-30 | 1996-09-17 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5660860A (en) * | 1991-01-30 | 1997-08-26 | Glaxo Wellcome Inc. | Water-dispersible tablets |
US5698221A (en) * | 1992-07-27 | 1997-12-16 | Patel; Suryakant Dahyabhai | Water-dispersible tablets |
US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
WO2013163738A1 (en) * | 2012-04-30 | 2013-11-07 | Mircea-Alexandru Mateescu | Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients |
US9220699B2 (en) | 2012-04-30 | 2015-12-29 | Karici Diagnostics Inc. | Complex containing carboxyl substituted starch and lipid for delayed delivery of active ingredients |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1405088A (en) | Slow release formulation | |
ES264040A1 (en) | Pharmaceutical formulations and their manufacture | |
GB1359614A (en) | Method for the manufacture of effervescent tablets | |
GB837451A (en) | Sustained release therapeutic composition and process of preparing same | |
US3121663A (en) | Carbon dioxide releasing laxative suppository | |
GB1095985A (en) | Free-flowing powders comprising choline chloride and a method for their manufacture | |
GB953626A (en) | Enteric-coated tablets of dextran sulphate ester and method of preparation thereof | |
GB630439A (en) | Improvements in or relating to pharmaceutical preparations | |
US2282290A (en) | Anthelmintic tablet | |
GB847370A (en) | Improvements in or relating to preparations for herbicidal, insecticidal or fertilizing purposes | |
GB1073772A (en) | Improvements in and relating to dental impression materials | |
GB739800A (en) | Aqueous pharmaceutical solutions of reserpine for parenteral administration | |
GB1460302A (en) | Tablet formulation | |
GB945981A (en) | Improvements in animal feeding stuffs | |
GB757155A (en) | Novel haemostatic compositions | |
ES354048A1 (en) | Npn-composition for ruminant animals | |
GB573589A (en) | Improvements in or relating to the manufacture of alginic materials | |
GB884576A (en) | Pharmaceutical compositions comprising an alkylamino substituted barbituric acid and salts thereof | |
GB1403062A (en) | Composition for treating burns and scalds | |
GB727870A (en) | Derivatives of sym-triacetylbenzene | |
GB973681A (en) | Tobacco compositions and preparation thereof | |
GB709283A (en) | Gelatine capsules containing chloral hydrate | |
GB751440A (en) | Improved muscle relaxant composition | |
GB1190838A (en) | Improvements in or relating to Dental Impression Materials | |
GB949287A (en) | Dry solid curing salt composition |